First Header Logo Second Header Logo

Connection

Michael Shapiro to Dyslipidemias

Back to Details
This is a "connection" page, showing publications Michael Shapiro has written about Dyslipidemias.
Michael Shapiro
Connection Strength
4.741
Dyslipidemias
  1. Warden BA, Fazio S, Shapiro MD. The PCSK9 revolution: Current status, controversies, and future directions. Trends Cardiovasc Med. 2020 04; 30(3):179-185.
    View in: PubMed
    Score: 0.639
  2. Wójcik C, Shapiro MD. Translating AHA/ACC cholesterol guidelines into meaningful risk reduction. J Fam Pract. 2019 05; 68(4):206;210;212;214;217;221B.
    View in: PubMed
    Score: 0.636
  3. Sandesara PB, Virani SS, Fazio S, Shapiro MD. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocr Rev. 2019 04 01; 40(2):537-557.
    View in: PubMed
    Score: 0.633
  4. Shapiro MD, Fazio S. Biologic bases of residual risk of cardiovascular events: A flawed concept. Eur J Prev Cardiol. 2018 11; 25(17):1831-1835.
    View in: PubMed
    Score: 0.609
  5. Shapiro MD, Tavori H, Fazio S. PCSK9: From Basic Science Discoveries to Clinical Trials. Circ Res. 2018 05 11; 122(10):1420-1438.
    View in: PubMed
    Score: 0.595
  6. Shapiro MD, Fazio S. Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering. Nat Rev Cardiol. 2017 06; 14(6):319-320.
    View in: PubMed
    Score: 0.554
  7. Shapiro MD, Fazio S. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk. Circ Res. 2016 Feb 19; 118(4):732-49.
    View in: PubMed
    Score: 0.510
  8. Ponir C, Annabathula R, Caldarera T, Penmetsa M, Seals A, Saha A, Moore JB, Bosworth HB, Ip EH, Shapiro MD, Pokharel Y. Availability of Specialty Services for Cardiovascular Prevention Practice in the Southeastern United States. South Med J. 2023 Nov; 116(11):848-856.
    View in: PubMed
    Score: 0.217
  9. Board C, Kelly MS, Shapiro MD, Dixon DL. PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy. J Cardiovasc Pharmacol. 2020 05; 75(5):410-420.
    View in: PubMed
    Score: 0.171
  10. Shapiro MD, Fazio S, Tavori H. Targeting PCSK9 for therapeutic gains. Curr Atheroscler Rep. 2015 Apr; 17(4):499.
    View in: PubMed
    Score: 0.120
  11. Surma S, Shapiro MD, Banach M. Breaking new ground in lipid management: Insights from the 2024 American College of Cardiology Scientific Sessions. Pharmacol Res. 2024 Jul; 205:107246.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.